Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Scientists Unlock Structure of Elusive ‘Stress’ Protein

Published: Friday, July 19, 2013
Last Updated: Friday, July 19, 2013
Bookmark and Share
New discovery paves the way for a transformation in drug treatments for depression, diabetes and osteoporosis.

Scientists working to design advanced medicines that are perfectly targeted to control the body’s natural receptors have made a major discovery using Diamond's Microfocus Macromolecular Crystallography beamline (I24). For the first time, they have been able to visualise and study the structure of CRF1, the protein receptor in the brain which controls our response to stress.

Heptares Therapeutics, a leading UK-based drug discovery and development company, was responsible for identifying the 3D structure of the ‘stress’ receptor, and their results are published today in the journal Nature. This discovery will help scientists to develop improved treatments for depression and anxiety. Furthermore, having identified the architecture of CRF1, scientists now have a template that can be used to accelerate research into other protein receptors that are known to be in the same ‘family’, including those that can be targeted to treat Type 2 diabetes and osteoporosis.

Stress-related diseases such as depression and anxiety are now commonplace. 1 in 4 people experience some kind of mental health problem in the course of a year. Over 105 million work days are lost to stress each year, costing UK employers £1.2 billion.

The UK also faces a major health challenge from diabetes. In the past 20 years, the number of people in the country suffering from diabetes has more than doubled to 2.9 million. By 2025 it is estimated that 5 million people will have diabetes, and that most of these cases will be Type 2 diabetes.

Heptares is a leader in the development of drugs targeting certain protein receptors, called G protein-coupled receptors. Currently 30% of drugs for a variety of diseases target these receptors, making them the largest and most important family of drug targets in the human body.

In the past, drug design has been largely the product of trial and error. Drugs would be developed and then tested until they had the desired effect. Because scientists lacked a comprehensive understanding of why and how the drugs were working, this approach could lead to unwanted side-effects.

A new way of making medicines, known as rational drug design, produces drugs that are specifically targeted to protein receptors in the body. By visualising the stress protein receptor at the atomic level, they were able, for the first time, to identify a ‘pocket’ in the structure. Computer technology will allow scientists to design a drug to fit precisely into this pocket, inhibiting the response of the ‘stress’ receptor. Such focused targeting will only affect the receptor they are aiming for and reduce the chance of unexpected side effects. The level of detail required for this work could only be achieved using the intense synchrotron light produced at Diamond Light Source, the UK’s synchrotron science facility in Oxfordshire. The synchrotron speeds electrons to near light speed, producing a light 10 billion times brighter than the sun. Around 2,500 scientists a year use this light to study samples, and its intensity allows them to visualise on a scale that is unobtainable in their home laboratories. Heptares is currently the biggest annual industrial user of the synchrotron.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Lighting Up A New Path For Novel Synthetic Polio Vaccine
Crystal structures and electron microscopy images are being used to develop a vaccine to target the polio virus.
Monday, February 16, 2015
Diamond Celebrates a Glittering Year of Crystallography
From film premieres to major scientific breakthroughs, Diamond Light Source helped make the International Year of Crystallography a memorable event.
Tuesday, December 23, 2014
Scientists Gain First Glimpse of One of Nature’s Measuring ‘Rulers’
New findings offer potential to outsmart bacterial infections.
Tuesday, December 16, 2014
Scientists Discover Bacteria’s Clever Defence Mechanism
Structure of EzrA protein could help identify new antibiotic targets.
Tuesday, November 18, 2014
Investment in New Capability for Materials Analysis
Johnson Matthey, Oxford University, Diamond Light Source announce the creation a state-of-the-art materials characterisation facility at the Harwell Science and Innovation Campus.
Thursday, August 07, 2014
Scientists Uncover Bacterial War Tactics
The discovery paves the way for new drugs to fight bacterial infections.
Tuesday, April 08, 2014
Novel Crystallography Beamline Takes Delivery of in Vacuum X-Ray Detector
The Diamond Light Source beamline will facilitate challenging research on DNA, RNA, native proteins and other building blocks of life.
Friday, April 04, 2014
‘Big Science’ uncovers another piece in the Alzheimer’s puzzle
Evidence found of the possible cause of brain-cell-damaging toxic iron.
Thursday, March 27, 2014
Year of Glittering Celebrations begins at Diamond Light Source
Activity to showcase 100 years of crystallography.
Tuesday, February 04, 2014
Funding Announced for New Biological Facilities at Diamond Light Source
Landmark silver doughnut-shaped building on the Harwell Campus has been granted £15.6 million for a new imaging centre for biology.
Friday, December 13, 2013
Smart New In Situ Tool Keeps X-Rays on Track
Diamond Light Source and the University of Manchester have successfully built a new beam imaging instrument, the Lancelot X-ray Beam Position Monitor (XBPM).
Friday, October 25, 2013
Diamond Sheds Light on Basic Building Blocks of Life
The UK’s national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 can be analysed at atomic and molecular level using synchrotron light.
Tuesday, February 19, 2013
Science Minister Shines Light on World’s Biggest Synchrotron Stage
On Thursday 2nd December, David Willetts MP, Minister for Universities and Science, will visit Diamond Light Source, the UK’s national synchrotron science facility, and officially open a unique new research station that can create molecular-scale 3D images of large objects such as aerospace and engineering components, and explore their structure in atomic-scale detail.
Thursday, December 02, 2010
Scientific News
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
Scientists Decode Structure at Root of Muscular Disease
Researchers at Rice University and Baylor College of Medicine have unlocked the structural details of a protein seen as key to treating a neuromuscular disease.
A Natural Light Switch
MIT scientists identify and map the protein behind a light-sensing mechanism.
First Complete Structural Study Of A Pegylated Protein
Significant data obtained at NUI Galway reports first crystal structure of a protein modified with a single PEG chain.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
New Mathematics Advances the Frontier of Macromolecular Imaging
Berkeley Lab’s M-TIP solves the reconstruction problem for fluctuation X-ray scattering.
Diamond Helps Develop New Way of Studying the Tiniest Microcrystals
Researchers have developed a new type of sample holder for ‘serial protein crystallography’.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos